1. Home
  2. FLGT vs BGB Comparison

FLGT vs BGB Comparison

Compare FLGT & BGB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulgent Genetics Inc.

FLGT

Fulgent Genetics Inc.

HOLD

Current Price

$19.59

Market Cap

511.0M

Sector

Health Care

ML Signal

HOLD

Logo Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

BGB

Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

HOLD

Current Price

$11.20

Market Cap

504.4M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
FLGT
BGB
Founded
2011
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
511.0M
504.4M
IPO Year
2016
N/A

Fundamental Metrics

Financial Performance
Metric
FLGT
BGB
Price
$19.59
$11.20
Analyst Decision
Buy
Analyst Count
3
0
Target Price
$28.33
N/A
AVG Volume (30 Days)
234.6K
150.7K
Earning Date
05-01-2026
01-01-0001
Dividend Yield
N/A
9.75%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$18,730,000.00
N/A
Revenue This Year
$10.09
N/A
Revenue Next Year
$12.18
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$13.46
$10.85
52 Week High
$31.04
$12.59

Technical Indicators

Market Signals
Indicator
FLGT
BGB
Relative Strength Index (RSI) 54.14 44.34
Support Level $19.20 $11.15
Resistance Level $20.24 $11.35
Average True Range (ATR) 0.54 0.04
MACD 0.07 -0.01
Stochastic Oscillator 66.52 34.21

Price Performance

Historical Comparison
FLGT
BGB

About FLGT Fulgent Genetics Inc.

Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in the laboratory services business and the therapeutic development business. The laboratory services business, which generates key revenue, includes technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue, and Foreign.

About BGB Blackstone Strategic Credit 2027 Term Fund of Beneficial Interest

Blackstone Strategic Credit Fund is a diversified, closed-end management investment company. Its primary investment objective is to seek high current income. The secondary objective of the fund is to seek the preservation of capital. Under normal market conditions, the Fund invests at least 80% of its Managed Assets in senior, secured floating-rate loans. The fund also invest in second-lien loans and high yield bonds and employs financial leverage, which may increase risk to the Fund. The Fund has a limited term and absent shareholder approval to extend the life of the Fund.

Share on Social Networks: